2. Sexually Transmitted Infections Treatment Guidelines, Centers for Disease Control and prevention, Morbidity and Mortality Weekly Report, Recommendations and Reports / Vol. 70 / No. 4 July 23, 2021. https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf

3. European Association of Urology Guidelines on Urological Infections, 2023 Edition. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urological-infections-2023.pdf

4. Jensen J.S., Cusini M., Gomberg M., Moi H., Wilson J., Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641–650. Doi: 10.1111/jdv.17972. Epub 2022 Feb 19. PMID: 35182080.

5. Horner P.J., Blee K., Falk L., van der Meijden W., Moi H. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928–937. Doi: 10.1177/0956462416648585. Epub 2016 May 4. PMID: 27147267.

6. Chlamydia infection. Clinical recommendations of the Ministry of Health of the Russian Federation, 2021 https://cr.minzdrav.gov.ru/schema/194_1. Russian (Хламидийная инфекция. Клинические рекомендации МЗ РФ, 2021 г. https://cr.minzdrav.gov.ru/schema/194_1).

7. Urogenital diseases caused by Mycoplasma genitalium. Clinical recommendations of the Ministry of Health of the Russian Federation, 2021. https://cr.minzdrav.gov.ru/schema/216_1. Russian (Урогенитальные заболевания, вызванные Mycoplasma genitalium. Клинические рекомендации МЗ РФ, 2021. https://cr.minzdrav.gov.ru/schema/216_1).

8. Bachmann L.H., Kirkcaldy R.D., Geisler W.M., et al. Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis

9. Bissessor M., Tabrizi S.N., Twin J., et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60(8):1228–1236. Doi:10.1093/cid/ciu1162

10. Paez-Canro C., et al. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and nonpregnant women. Cochrane Database Syst Rev, 2019. 2019: CD010871. https://pubmed.ncbi.nlm.nih.gov/30682211

11. Bebear C.M. et al. Activity of moxifloxacin against the urogenital mycoplasma Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 2008;14:801–805.

12. Takahashi S., Hamasuna R., Yasuda M., Ishikawa K., Hayami H., Uehara S., Yamamoto S., Minamitani S., Kadota J., Iwata S., Kaku M., Watanabe A., Sato J., Hanaki H., Masumori N., Kiyota H., Egawa S., Tanaka K., Arakawa S., Fujisawa M., Kumon H., Wada K., Kobayashi K., Matsubara A., Matsumoto T., Eto M., Tatsugami K., Kuroiwa K.,Ito K., Hosobe T., Hirayama H., Narita H., Yamaguchi T., Ito S., Sumii T.,Kawai S., Kanokogi M., Kawano H., Chokyu H., Uno S., Monden K., Kaji S., Kawahara M., Takayama K., Ito M., Yoshioka M., Kano M., Konishi T., Kadena H., Nishi S., Nishimura H., Yamauchi T., Maeda S., Horie M.,Ihara H., Matsumura M., Shirane T., Takeyama K., Akiyama K., Takahashi K., Ikuyama T., Inatomi H., Yoh M. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. J Infect Chemother. 2016;22(9):581–86. Doi: 10.1016/j.jiac.2016.06.010. Epub 2016 Jul 21. PMID: 27452428.

13. Waites K.B., Duffy L.B., Schmid T., Crabb D., Pate M.S., Cassell G.H. In vitro susceptibilities of Mycoplasma pneu-moniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 1991;35(6):1181–1185. Doi: 10.1128/AAC.35.6.1181. PMID: 1929260; PMCID: PMC284307.

14. Jensen J.S., Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015;15:343. Doi: 10.1186/s12879-015-1041-6. PMID: 26286546; PMCID: PMC4545773.

15. Zarucheynova O.V. Development of a complex of diagnostic kits for the detection, identification and determination of antibiotic sensitivity of urogenital mycoplasmas. Abstract of the dissertation for the degree of Candidate of Biological Sciences. 2015, p. 1–25. Russian (Заручейнова О.В. Разработка комплекса диагностических наборов для выявления, идентификации и определения чувствительности к антибиотикам урогенитальных микоплазм. Автореферат диссертации на соискание ученой степени кандидата биологических наук. 2015 г. С. 1–25).

16. Burkhardt O., Welte T. 10 years’ experience with the pneumococcal quinolone moxifloxacin. Expert Rev Anti Infect Ther. 2009;7(6):645–68.

17. Schwebke J.R., Rompalo A., Taylor S., Seña A.C., Martin D.H., Lopez L.M., Lensing S., Lee J.Y. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis. 2011;52(2):163–170. Doi: 10.1093/cid/ciq074. PMID: 21288838; PMCID: PMC3106252.

18. Manhart L.E., Gillespie C.W., Lowens M.S., Khosropour C.M., Colombara D.V., Golden M.R., Hakhu N.R., Thomas K.K., Hughes J.P., Jensen NL, Totten P.A. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56(7):934–942. Doi: 10.1093/cid/cis1022. Epub 2012 Dec 7. PMID: 23223595; PMCID: PMC3588116.

19. Jernberg E., Moghaddam A., Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. International Journal of STD & AIDS 2008;19:676–679. Doi:10.1258/ijsa.2008.00803.